Skip to main content

Autoimmune & autoinflammatory

Seronegative APS debate

Seronegative APS is the contested idea that some patients have antiphospholipid syndrome despite negative standard antibodies - a genuine scientific debate with practical stakes for people with unexplained clots and losses.

Key points

The essentials at a glance.

What to look out for, which tests matter, who treats it, and what usually happens next.

  • The concept: classic APS clinical features - thromboses, recurrent pregnancy loss, livedo - with persistently negative standard antibody tests

  • Proposed explanations: non-criteria antibodies (anti-phosphatidylserine/prothrombin, anti-domain I), antibody levels fluctuating below thresholds, or misattribution

  • Sceptics note the label risks over-diagnosis and inappropriate lifelong anticoagulation

  • Practical middle ground: retest at intervals, test during quiescence, consider non-criteria antibodies in research-capable labs, and hunt alternative thrombophilias

  • Treatment without positive antibodies is individualised risk management, not automatic APS therapy

Understanding it

About Seronegative APS debate.

The debate is honest on both sides. Proponents point to patients with textbook clinical APS - the young strokes, the placental disease, the livedo racemosa - whose standard three tests stay stubbornly negative, and to studies finding non-criteria antibodies in a meaningful slice of them. Sceptics reply that unexplained thrombosis is common, that the non-criteria assays are poorly standardised, and that a syndrome defined by laboratory criteria cannot coherently be diagnosed without them - warning that the label can condemn patients to indefinite warfarin on soft evidence.

For the patient in the middle, the sensible pathway avoids both dismissal and dogma: repeat criteria testing (levels fluctuate, and anticoagulation or the acute event can distort results), pursue the broader thrombophilia and vasculitis work-up, ask whether non-criteria antibody testing is available through a specialist centre, and let treatment decisions rest on individual thrombotic risk rather than on winning the naming argument. An APS-experienced clinician who explains the uncertainty candidly is the real prize here. In many parts of the UK, a routine NHS referral to the relevant specialist clinic currently means waiting many months - sometimes more than a year for the rarest conditions - whereas an initial appointment with a private consultant is typically available within around two weeks, with investigations arranged soon after.

Frequently asked

Common questions about Seronegative APS debate.

Quick, plain-English answers to what people ask us most.

  • What is seronegative antiphospholipid syndrome (APS)?

    Seronegative APS is the contested idea that some patients have antiphospholipid syndrome - a condition causing blood clots and pregnancy complications - despite negative standard antibody tests, representing a genuine scientific debate within the field.

  • Why is seronegative APS controversial?

    Standard APS diagnosis relies on specific positive antibody tests, so diagnosing APS without them is debated among specialists, with some arguing additional, non-standard antibodies may be responsible in certain patients with a very suggestive clinical picture.

  • What are the symptoms that raise suspicion of seronegative APS?

    Suspicion arises in people with a strongly suggestive clinical history - recurrent blood clots or pregnancy complications typical of APS - but persistently negative standard antibody testing.

  • How is seronegative APS investigated?

    Investigation can include repeat standard testing over time (as antibody levels can fluctuate) and, in specialist centres, testing for additional, non-standard antiphospholipid-related antibodies not included in routine panels.

  • How is seronegative APS treated?

    When the clinical picture strongly suggests APS despite negative testing, treatment with blood-thinning medication similar to confirmed APS may be considered on a case-by-case basis, weighing the risks and benefits carefully with a specialist.

  • When should I see a specialist about possible seronegative APS?

    See a doctor if you have a history very suggestive of APS despite negative standard testing. A private haematologist or rheumatologist experienced in this debate can typically be seen within about two weeks.